5-Feb-2026
TipRanks (Thu, 5-Feb 9:50 AM ET)
Genius Sports strikes a $1.2B deal to acquire sports media company Legend
Seeking Alpha News (Thu, 5-Feb 6:40 AM ET)
TipRanks (Thu, 5-Feb 6:27 AM ET)
Business Wire (Thu, 5-Feb 6:00 AM ET)
TipRanks (Mon, 2-Feb 8:50 AM ET)
TipRanks (Mon, 2-Feb 8:00 AM ET)
TipRanks (Sun, 1-Feb 10:50 AM ET)
Business Wire (Thu, 22-Jan 8:00 AM ET)
Genius Sports' New Platform with FanDuel Brings Real-Time Game Insights to Over 300 NBA Broadcasts
Market Chameleon (Wed, 3-Dec 6:15 AM ET)
Market Chameleon (Wed, 3-Dec 4:03 AM ET)
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
Genius Sports trades on the NYSE stock market under the symbol GENI.
As of February 5, 2026, GENI stock price declined to $6.19 with 34,737,820 million shares trading.
GENI has a beta of 0.89, meaning it tends to be less sensitive to market movements. GENI has a correlation of 0.11 to the broad based SPY ETF.
GENI has a market cap of $1.44 billion. This is considered a Small Cap stock.
Last quarter Genius Sports reported $166 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$.18.
In the last 3 years, GENI traded as high as $13.73 and as low as $3.55.
The top ETF exchange traded funds that GENI belongs to (by Net Assets): IWM, ARKW, IWO, WCMI, VTWO.
GENI has underperformed the market in the last year with a price return of -34.7% while the SPY ETF gained +13.8%. GENI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.0% and -36.4%, respectively, while the SPY returned +0.6% and -1.1%, respectively.
GENI support price is $8.27 and resistance is $8.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GENI shares will trade within this expected range on the day.